Intensive-Phase Treatment Outcomes among Hospitalized Multidrug-Resistant Tuberculosis Patients: Results from a Nationwide Cohort in Nigeria

Hdl Handle:
http://hdl.handle.net/10144/315844
Title:
Intensive-Phase Treatment Outcomes among Hospitalized Multidrug-Resistant Tuberculosis Patients: Results from a Nationwide Cohort in Nigeria
Authors:
Oladimeji, Olanrewaju; Isaakidis, Petros; Obasanya, Olusegun J; Eltayeb, Osman; Khogali, Mohammed; Van den Bergh, Rafael; Kumar, Ajay M V; Hinderaker, Sven Gudmund; Abdurrahman, Saddiq T; Lawson, Lovett; Cuevas, Luis E
Journal:
PloS ONE
Abstract:
Nigeria is faced with a high burden of Human Immunodeficiency Virus (HIV) infection and multidrug-resistant tuberculosis (MDR-TB). Treatment outcomes among MDR-TB patients registered across the globe have been poor, partly due to high loss-to-follow-up. To address this challenge, MDR-TB patients in Nigeria are hospitalized during the intensive-phase(IP) of treatment (first 6-8 months) and are provided with a package of care including standardized MDR-TB treatment regimen, antiretroviral therapy (ART) and cotrimoxazole prophylaxis (CPT) for HIV-infected patients, nutritional and psychosocial support. In this study, we report the end-IP treatment outcomes among them.
Publisher:
Public Library of Science
Issue Date:
Apr-2014
URI:
http://hdl.handle.net/10144/315844
DOI:
10.1371/journal.pone.0094393
PubMed ID:
24722139
Language:
en
ISSN:
1932-6203
Appears in Collections:
Operational Research Courses

Full metadata record

DC FieldValue Language
dc.contributor.authorOladimeji, Olanrewajuen_GB
dc.contributor.authorIsaakidis, Petrosen_GB
dc.contributor.authorObasanya, Olusegun Jen_GB
dc.contributor.authorEltayeb, Osmanen_GB
dc.contributor.authorKhogali, Mohammeden_GB
dc.contributor.authorVan den Bergh, Rafaelen_GB
dc.contributor.authorKumar, Ajay M Ven_GB
dc.contributor.authorHinderaker, Sven Gudmunden_GB
dc.contributor.authorAbdurrahman, Saddiq Ten_GB
dc.contributor.authorLawson, Lovetten_GB
dc.contributor.authorCuevas, Luis Een_GB
dc.date.accessioned2014-04-15T16:02:24Z-
dc.date.available2014-04-15T16:02:24Z-
dc.date.issued2014-04-
dc.identifier.citationIntensive-Phase Treatment Outcomes among Hospitalized Multidrug-Resistant Tuberculosis Patients: Results from a Nationwide Cohort in Nigeria. 2014, 9 (4):e94393 PLoS ONEen_GB
dc.identifier.issn1932-6203-
dc.identifier.pmid24722139-
dc.identifier.doi10.1371/journal.pone.0094393-
dc.identifier.urihttp://hdl.handle.net/10144/315844-
dc.description.abstractNigeria is faced with a high burden of Human Immunodeficiency Virus (HIV) infection and multidrug-resistant tuberculosis (MDR-TB). Treatment outcomes among MDR-TB patients registered across the globe have been poor, partly due to high loss-to-follow-up. To address this challenge, MDR-TB patients in Nigeria are hospitalized during the intensive-phase(IP) of treatment (first 6-8 months) and are provided with a package of care including standardized MDR-TB treatment regimen, antiretroviral therapy (ART) and cotrimoxazole prophylaxis (CPT) for HIV-infected patients, nutritional and psychosocial support. In this study, we report the end-IP treatment outcomes among them.en_GB
dc.language.isoenen
dc.publisherPublic Library of Scienceen_GB
dc.rightsPublished by Public Library of Science, [url]http://www.plosone.org/[/url] Archived on this site by Open Access permissionen_GB
dc.subjectAntibiotic Resistanceen_GB
dc.subjectTuberculosisen_GB
dc.subjectCourse on Operational Researchen_GB
dc.subjectHIV/AIDSen_GB
dc.titleIntensive-Phase Treatment Outcomes among Hospitalized Multidrug-Resistant Tuberculosis Patients: Results from a Nationwide Cohort in Nigeriaen
dc.identifier.journalPloS ONEen_GB

Related articles on PubMed

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.